RESUMO
PURPOSE: This study aimed to determine if initial MRI findings could predict a pathological complete response (pCR) following neoadjuvant systemic therapy (NST) in HER2-positive breast cancers. METHODS: The study retrospectively included 111 patients (Center 1, training set) and 71 patients (Center 2, validation set) with HER2-positive cancer who underwent NST. Initial clinicopathological data and MRI findings were recorded. Continuous variables were analyzed using the Mann-Whitney and Student's t-tests, while categorical variables were analyzed using the χ2 or Fisher's exact test. Univariate analysis was conducted to determine the associations between these variables and pathological complete response (pCR), defined as the absence of invasive malignant cells in the breast and lymph nodes. Interobserver reproducibility was assessed for associated non-mass enhancement (NME) parameter by analyzing 50 MR studies (intraclass correlation coefficient). RESULTS: pCR was achieved in 67 patients, 51 (46 %) from Center 1 and 16 (23%) from Center 2 (p = 0.003), with significant differences between Centers 1 and 2 in tumor-infiltrating lymphocyte levels and lymphovascular invasion (p < 0.001). The initial presence of suspicious associated NME was the only significant parameter predictive of pCR (p < 0.001 for Center 1 and 0.04 for Center 2). The inter-observer reproducibility for this MRI feature was good, with an intraclass correlation coefficient of 0.872 (95 % CI: 0.73-1.00). CONCLUSION: The presence of suspicious associated NME in HER2-positive cancers on the initial MRI study was predictive of achieving pCR after NST. This significant preliminary finding warrants confirmation through prospective multicenter studies.
Assuntos
Neoplasias da Mama , Terapia Neoadjuvante , Resposta Patológica Completa , Receptor ErbB-2 , Adulto , Idoso , Feminino , Humanos , Pessoa de Meia-Idade , Neoplasias da Mama/diagnóstico por imagem , Neoplasias da Mama/terapia , Imageamento por Ressonância Magnética , Terapia Neoadjuvante/métodos , Valor Preditivo dos Testes , Receptor ErbB-2/metabolismo , Reprodutibilidade dos Testes , Estudos Retrospectivos , Resultado do TratamentoRESUMO
OBJECTIVE: Despite recent improvements in medical imaging, the final diagnosis and biopathologic characterization of breast cancers currently still requires biopsies. Ultrasound is commonly used for clinical examination of breast masses. B-Mode and shear wave elastography (SWE) are already widely used to detect suspicious masses and differentiate benign lesions from cancers. But additional ultrasound modalities such as backscatter tensor imaging (BTI) could provide relevant biomarkers related to tissue organization. Here we describe a 3-D multiparametric ultrasound approach applied to breast carcinomas in the aims of (i) validating the ability of BTI to reveal the underlying organization of collagen fibers and (ii) assessing the complementarity of SWE and BTI to reveal biopathologic features of diagnostic interest. METHODS: Three-dimensional SWE and BTI were performed ex vivo on 64 human breast carcinoma samples using a linear ultrasound probe moved by a set of motors. Here we describe a 3-D multiparametric representation of the breast masses and quantitative measurements combining B-mode, SWE and BTI. RESULTS: Our results reveal for the first time that BTI can capture the orientation of the collagen fibers around tumors. BTI was found to be a relevant marker for assessing cancer stages, revealing a more tangent tissue orientation for in situ carcinomas than for invasive cancers. In invasive cases, the combination of BTI and SWE parameters allowed for classification of invasive tumors with respect to their grade with an accuracy of 95.7%. CONCLUSION: Our results highlight the potential of 3-D multiparametric ultrasound imaging for biopathologic characterization of breast tumors.
Assuntos
Neoplasias da Mama , Técnicas de Imagem por Elasticidade , Feminino , Humanos , Neoplasias da Mama/patologia , Técnicas de Imagem por Elasticidade/métodos , Ultrassonografia Mamária/métodos , Abordagem GRADE , Mama/diagnóstico por imagem , Mama/patologia , Colágeno , Sensibilidade e Especificidade , Reprodutibilidade dos Testes , Diagnóstico DiferencialRESUMO
Para la realización de un examen de RM mamaria se necesita un protocolo de adquisición de imágenes de óptima calidad con la utilización de una bobina específica de mama, alta resolución espacial (los criterios morfológicos tienen un valor diagnóstico significativamente mayor que los criterios cinéticos) e inyección de contraste en bolo. La interpretación de todo realce anormal debe ser descrito según la clasificación BIRADS-RM. Las indicaciones de la RM son: diagnóstico de ruptura intracapsular ( prótesis de silicona), búsqueda de recidiva local en una mama tratada, búsqueda de un primitivo mamario ( paciente N+), extensión local de un cáncer de mama ( mamas densas), seguimiento de un cáncer bajo tratamiento neoadyuvante y detección precoz en mujeres de alto riesgo (contexto genético). Puede ser igualmente de utilidad en caso de problema diagnóstico no resuelto por las imágenes estándar (alto valor predictivo negativo). En pacientes con cáncer de mama es importante señalar la necesidad de que el radiólogo trabaje en un equipo multidisciplinario y evalúe los realces sospechosos en RM con biopsia bajo guía de RM.